Minnesota warehouse barred from distributing products after persistent rodent findings
A federal court barred Gold Star Distribution and its owner from distributing FDA-regulated products from their Minneapolis warehouse until operations meet legal requirements. The order followed inspections citing persistent insanitary conditions, including rodent-related concerns.
By DoomRadar · Published on DoomRadar . Updated .
Based on one source with available article excerpts. Source-linked claims are not independent confirmation.
What happened
The U.S. District Court for the District of Minnesota entered a permanent injunction against Gold Star Distribution and owner Bassam Abu Samrah on Sept. 21, 2026. [1]
References for this detail (1)
- Federal Court Enters Consent Decree Against Gold Star Distribution, Inc. Following Persistent Insanitary Warehouse Conditionsfda.gov · Recorded source date: Sep 23, 2026, 10:16 PM UTC
The order stops the Minneapolis-based warehouse operator from distributing FDA-regulated food, drugs, medical devices and cosmetics until it fixes its operations to meet federal legal requirements. [1]
References for this detail (1)
- Federal Court Enters Consent Decree Against Gold Star Distribution, Inc. Following Persistent Insanitary Warehouse Conditionsfda.gov · Recorded source date: Sep 23, 2026, 10:16 PM UTC
The FDA and Minnesota Department of Agriculture investigated the facility with other state regulators after repeated inspections identified persistent insanitary conditions associated with rodents. [1]
References for this detail (1)
- Federal Court Enters Consent Decree Against Gold Star Distribution, Inc. Following Persistent Insanitary Warehouse Conditionsfda.gov · Recorded source date: Sep 23, 2026, 10:16 PM UTC
Minnesota regulators twice issued food embargo and cease-and-desist orders in November 2025 and revoked the defendants’ food wholesale license, according to the FDA account. [1]
References for this detail (1)
- Federal Court Enters Consent Decree Against Gold Star Distribution, Inc. Following Persistent Insanitary Warehouse Conditionsfda.gov · Recorded source date: Sep 23, 2026, 10:16 PM UTC
Context from the sources
The FDA said it had inspected the facility five times before the 2025 inspection, while the Minnesota Department of Agriculture conducted 26 inspections between 2013 and 2025. [1]
Explore the sources and reporting timeline
1 source links · 1 domains
These counts describe the references, not independent confirmations. Different outlets can repeat the same original report.
Source timeline
Oldest to newest among the available source dates, not a chronology of the incident. Article publication dates come from the source; other recorded dates may reflect when a link was found.
What this could mean for you
Some products distributed through the facility could become harder to find locally.
The injunction prevents the warehouse from distributing FDA-regulated goods until required corrective measures are completed.
Reported basis: [1] · The possible effect is interpretation.
Depends on: The affected products must depend on Gold Star or replacement distribution capacity.
Consumers could face uncertainty about the storage history of products linked to the warehouse.
Regulators cited persistent insanitary conditions and rodent-related findings during repeated inspections.
Reported basis: [1] · The possible effect is interpretation.
Depends on: A product must have been stored or handled at the facility during the affected period.
Possible consequences, not a forecast. Their relevance depends on your location and the conditions above.
For your country
Choose a country to check how this event could affect you.
What changes the outlook
Risk increases if…
A failure to satisfy the court’s required corrective measures would prolong the distribution ban.
Further regulatory findings involving products or storage conditions could expand the response.
Pressure eases if…
Successful compliance with the court’s requirements could allow distribution to resume.
Replacement distributors could reduce product-access effects while the injunction remains in place.
Still unclear
The sources do not identify which brands or quantities of products were affected.
The sources do not state how long compliance will take or whether any contaminated products reached consumers.
Market implications
Market impact
Sources (1)
References for the reported details. Separate links do not necessarily mean independent confirmation.
Available excerpt
A U.S. Food and Drug Administration investigation resulted in a federal court order, dated Sept. 21, 2026, stopping a warehouse operator from distributing FDA-regulated products…A short excerpt from our source record; open the original for the full article.
AI-assisted analysis · . Based on linked headlines and available excerpts. Methodology · Report an error.